| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT05735639 THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) |
Enrollment reduced: 6660 -> 3175 participants |
| 2026-05-27 | NCT05038228 High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial… |
date change Primary completion pushed: 2026-04-08 -> 2026-05-29 |
| 2026-05-27 | NCT05038228 High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial… |
date change Completion pushed: 2026-04-08 -> 2026-05-29 |
| 2026-05-27 | NCT04618913 Anticoagulation in Patients With Venous Thromboembolism and Cancer |
date change Primary completion pushed: 2026-04-06 -> 2026-06-30 |
| 2026-05-27 | NCT04618913 Anticoagulation in Patients With Venous Thromboembolism and Cancer |
date change Completion pushed: 2026-04-06 -> 2026-06-30 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-05 | NCT07629999 Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06650501 | Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia | Staphylococcus Aureus Endocarditis | Recruiting |
| NCT05735639 | THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) | Venous Thromboembolism | Recruiting |
| Phase 1 | |||
| NCT07629999 | Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in… | Healthy Volunteers | Not Yet Recruiting |
| Not specified | |||
| NCT07358416 | Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. | Thrombosis | Active, Not Recruiting |
| NCT04618913 | Anticoagulation in Patients With Venous Thromboembolism and Cancer | Neoplasms | Active, Not Recruiting |
| NCT05038228 | High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial… | Atrial Fibrillation | Active, Not Recruiting |